Wednesday, March 24, 2021 9:00:03 PM
“When do you expect FDA- approvals for either the intravenous or inhaled formulations?
We cannot speculate on the likelihood or timing of FDA approvals. Day 28 top-line results from the U.S. Phase 2b/3 trial with the IV formulation of RLF-100™ were announced in February 2021. We anticipate longer term day 60 data to follow in March...”
https://relieftherapeutics.com/investor-relations#
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM